Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura S Mertens

Showing results (1-10 of 150) with videos related to

Pageof 15
Sort By:
Nature Reviews. Urology|June 21, 2017
Bladder cancer: oligometastases and imagingLaura S Mertens, Simon Horenblas
Scandinavian Journal of Urology|June 13, 2017
Related to: [<sup>18</sup>F]Fluorodeoxyglucose-positron emission tomography/computed tomography response evaluation can predict histological response at surgery after induction chemotherapy for oligometastatic bladder cancerLaura S Mertens, Simon Horenblas
Nature Reviews. Clinical Oncology|April 22, 2026
Systemic induction therapy and the expanding frontier of bladder preservation in MIBCLaura S Mertens, Ashish M Kamat
The Lancet. Oncology|December 24, 2023
Accelerating neoadjuvant chemotherapy for muscle-invasive bladder cancerLaura S Mertens, Michiel S van der Heijden
Nature Reviews. Urology|August 17, 2023
Bladder cancer oligometastases - definition and treatmentLaura S Mertens, Sarah P Psutka, Maria Carmen Mir
European Urology|October 6, 2022
Positron Emission Tomography/Computed Tomography for Staging of Bladder Cancer: A Continuing Clinical ControversyLaura S Mertens, Richard P Meijer, J Alfred Witjes
Nature Reviews. Urology|April 22, 2026
Worse bladder cancer outcomes in women than in men - bias, biology or both?Niyati Lobo, Tahlita C M Zuiverloon, Laura S Mertens
European Urology|July 2, 2026
Re: Twelve-month Results from the CISTO Study Comparing Radical Cystectomy Versus Bladder-sparing Therapy for Recurrent High-grade Non-muscle-invasive Bladder Cancer: Recurrent High-risk NMIBC: One Bladder, Choose WiselyRoberto Contieri, Antoine G van der Heijden, Laura S Mertens
Annals of Surgical Oncology|April 24, 2020
ASO Author Reflections: How to Detect Peritoneal Metastases of Urachal Carcinoma? The Value of Diagnostic Laparoscopy and Abdominal Cytology in Staging This Rare MalignancyLaura E Stokkel, Laura S Mertens, Bas W G van Rhijn
European Urology|June 16, 2016
Re: Trends in the Use of Perioperative Chemotherapy for Localized and Locally Advanced Muscle-invasive Bladder Cancer: A Sign of Changing TidesTom J N Hermans, Laura S Mertens, Bas W G van Rhijn
Pageof 15

Showing results (1-10 of 150) with videos related to

Sort By:
Pageof 15
Nature Reviews. Urology|June 21, 2017
Bladder cancer: oligometastases and imagingLaura S Mertens, Simon Horenblas
Scandinavian Journal of Urology|June 13, 2017
Related to: [<sup>18</sup>F]Fluorodeoxyglucose-positron emission tomography/computed tomography response evaluation can predict histological response at surgery after induction chemotherapy for oligometastatic bladder cancerLaura S Mertens, Simon Horenblas
Nature Reviews. Clinical Oncology|April 22, 2026
Systemic induction therapy and the expanding frontier of bladder preservation in MIBCLaura S Mertens, Ashish M Kamat
The Lancet. Oncology|December 24, 2023
Accelerating neoadjuvant chemotherapy for muscle-invasive bladder cancerLaura S Mertens, Michiel S van der Heijden
Nature Reviews. Urology|August 17, 2023
Bladder cancer oligometastases - definition and treatmentLaura S Mertens, Sarah P Psutka, Maria Carmen Mir
European Urology|October 6, 2022
Positron Emission Tomography/Computed Tomography for Staging of Bladder Cancer: A Continuing Clinical ControversyLaura S Mertens, Richard P Meijer, J Alfred Witjes
Nature Reviews. Urology|April 22, 2026
Worse bladder cancer outcomes in women than in men - bias, biology or both?Niyati Lobo, Tahlita C M Zuiverloon, Laura S Mertens
European Urology|July 2, 2026
Re: Twelve-month Results from the CISTO Study Comparing Radical Cystectomy Versus Bladder-sparing Therapy for Recurrent High-grade Non-muscle-invasive Bladder Cancer: Recurrent High-risk NMIBC: One Bladder, Choose WiselyRoberto Contieri, Antoine G van der Heijden, Laura S Mertens
Annals of Surgical Oncology|April 24, 2020
ASO Author Reflections: How to Detect Peritoneal Metastases of Urachal Carcinoma? The Value of Diagnostic Laparoscopy and Abdominal Cytology in Staging This Rare MalignancyLaura E Stokkel, Laura S Mertens, Bas W G van Rhijn
European Urology|June 16, 2016
Re: Trends in the Use of Perioperative Chemotherapy for Localized and Locally Advanced Muscle-invasive Bladder Cancer: A Sign of Changing TidesTom J N Hermans, Laura S Mertens, Bas W G van Rhijn
Pageof 15